FREE Account Opening + No Clearing Fees
Loading...

Vanta Bioscience IPO vs Worth Peripherals IPO

Comparision between Vanta Bioscience IPO and Worth Peripherals IPO.

IPO Details

Vanta Bioscience IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Worth Peripherals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Vanta Bioscience IPO Worth Peripherals IPO
Logo Vanta Bioscience IPO Logo Worth Peripherals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Inventure Merchant Banker Services Pvt Ltd Pantomath Capital Advisors Pvt Ltd
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Vanta Bioscience IPO is up to ₹7.56 Cr whereas the issue size of the Worth Peripherals IPO is up to ₹18.28 Cr. The final issue price of Vanta Bioscience IPO is ₹50.00 per share and of Worth Peripherals IPO is ₹43.00 per share.

  Vanta Bioscience IPO Worth Peripherals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹40.00 per share
Issue Price (Upper) ₹43.00 per share
Issue Price (Final) ₹50.00 per share ₹43.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 15,12,000 shares 42,51,000 shares
Issue Size Total (Amount) up to ₹7.56 Cr up to ₹18.28 Cr

IPO Timetable

Vanta Bioscience IPO opens on Sep 25, 2017, while Worth Peripherals IPO opens on Sep 15, 2017. The closing date of Vanta Bioscience IPO and Worth Peripherals IPO is Sep 27, 2017, and Sep 19, 2017, respectively.

  Vanta Bioscience IPO Worth Peripherals IPO
Anchor Bid Date
Issue Open Sep 25, 2017 Sep 15, 2017
Issue Close Sep 27, 2017 Sep 19, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Vanta Bioscience IPO P/E ratio is , as compared to Worth Peripherals IPO P/E ratio of .

  Vanta Bioscience IPO Worth Peripherals IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 8124.79 8571.20 6154.24 5449.23 4477.35
Total Revenue 13214.73 12740.00 10778.41 8423.23 5935.17
Profit After Tax 731.65 646.62 601.63 515.04 345.76
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Vanta Bioscience IPO retail investors (RII) are offered while in Worth Peripherals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Vanta Bioscience IPO and 0 shares in Worth Peripherals IPO.

  Vanta Bioscience IPO Worth Peripherals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 0 shares
NII 21,25,500 shares
RII 21,25,500 shares
Employee
Others
Total 42,51,000 shares

Bids Received (Subscription)

Vanta Bioscience IPO subscribed in total, whereas Worth Peripherals IPO subscribed 2.62x.

  Vanta Bioscience IPO Worth Peripherals IPO
QIB (times)
NII (times) 1.77x
Big NII (times)
Small NII (times)
RII (times) 3.25x
Employee (times)
Other (times)
Total (times) 2.62x

Comments

Add a public comment...